Advanced Biomed Inc. is a holding company that operates, through its subsidiaries, Advanced Biomed Inc. (Taiwan) and Advanced Biomed HK Limited. The Company is engaged in the provision of assay products and services for cancer patients. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. It has developed a microfluidic technology platform to integrate research and development, design, and manufacture of biochips and microfluidic chips. The platform combines its patented chip technology and will enable localized operations of a variety of microfluidic chips, biosensors made by semiconductor fabrication technology, and integrated application patented technology. The Company offers devices, such as A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre-Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip.
公司代碼ADVB
公司名稱Advanced Biomed Inc
上市日期Mar 06, 2025
CEO- -
員工數量31
證券類型Ordinary Share
年結日Mar 06
公司地址401 Ryland St
城市RENO
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編89502
電話1862120510823
網址http://www.advanbiomed.com/
公司代碼ADVB
上市日期Mar 06, 2025
CEO- -